Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although trace elements have been implicated in the pathogenesis of
amyotrophic lateral sclerosis
(
ALS
) for a long time, new evidence has connected familial
ALS
with the metalloenzyme copper-zinc superoxide dismutase, thus reinforcing the study of their metabolism. This work presents the results of serum and cerebrospinal fluid levels of
copper
, zinc, manganese and magnesium, by atomic absorption spectrophotometry. Statistically significant decreased cerebrospinal fluid and serum
copper
levels were found in patients compared to the control group (20.25 +/- 7.09 vs. 30.86 +/- 16.02 SD micrograms/l and 913.21 +/- 165.55 vs. 1020.17 +/- 197.76 SD micrograms/l) while serum manganese levels were found to be increased in patients (3.59 +/- 0.89 SD micrograms/l) compared to controls (3.03 +/- 1.23 SD micrograms/l). Zinc and magnesium levels were unchanged. Our findings indicate an essential trace element imbalance in the disease.
...
PMID:Essential trace element alterations in amyotrophic lateral sclerosis. 910 24
The statistical tests analysis of variance, analysis of covariance, correlation coefficient, Kolmogorov-Smirnov test, t-test, and Tukey test were applied to
copper
, magnesium, manganese, and zinc content in serum (S) and in cerebrospinal fluid (CSF) of controls and of a sporadic form of
Amyotrophic Lateral Sclerosis
(
ALS
) disease. This is carried out in order to evaluate statistically the possible relationships among the trace elements when
ALS
patients and controls are considered as independent groups, within sex groups and within age decades of both patients and control classes. A statistically significant difference between older controls (age > 40) and
ALS
patients (age > 40) for
copper
in CSF,
copper
in S, manganese in S, and zinc in CSF was found. Statistically significant correlation coefficients within the different classes formed for this study were observed. Within this pool, a correlation of patient group can differ statistically from the corresponding one of controls and vice versa. Thus, this correlation could be characteristic of the group from which is extracted, e.g., the correlation between
copper
in S and zinc in S, which is characteristic of
ALS
patients when considered as an independent group as well as members of the male patient class.
...
PMID:Trace elements, age, and sex in amyotrophic lateral sclerosis disease. 916 64
Although a consensus that Alzheimer's disease (AD) is a single disease has not yet been reached, the involvement of the amyloid precursor protein (APP) and beta A4 (A beta) in the pathologic changes advances our understanding of the underlying molecular alterations. Increasing evidence implicates oxidative stress in the neurodegenerative process of AD. This hypothesis is based on the toxicity of beta A4 in cell cultures, and the findings that aggregation of beta A4 can be induced by metal-catalyzed oxidation and that free oxygen radicals might be involved in APP metabolism. Another neurological disorder, familial
amyotrophic lateral sclerosis
(FALS), supports our view that AD and FALS might be linked through a common mechanism. In FALS, SOD-Cu(I) complexes are affected by hydrogen peroxide and free radicals are produced. In AD, the reduction of
Cu(II)
to Cu(I) by APP involves an electron-transfer reaction and could also lead to a production of hydroxyl radicals. Thus,
copper
-mediated toxicity of APP-
Cu(II)
/(I) complexes may contribute to neurodegeneration in AD.
...
PMID:Amyloid precursor protein, copper and Alzheimer's disease. 918 Oct 45
A subpopulation of familial cases of
amyotrophic lateral sclerosis
has been linked to mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1). There is in vitro evidence that certain SOD1 mutants, in addition to their normal dismutation function, show increased ability of the enzyme to act as a peroxidase. This reaction is sensitive to inhibition by
copper
chelators. To test this hypothesis in vivo, we administered the
copper
chelator d-penicillamine to a transgenic mouse model of familial
amyotrophic lateral sclerosis
overexpressing a mutated form of human SOD1. We demonstrate that oral administration of d-penicillamine is able to delay the onset of the disease and extend the survival of these mice. Histological studies also showed a decreased loss of facial motor neurons in d-penicillamine-treated transgenic mice, corroborating the slower evolution of the disease in these animals. These results suggest that
copper
chelators may benefit patients with familial
amyotrophic lateral sclerosis
linked to mutations in the SOD1 gene.
...
PMID:The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. 924 Apr 14
Copper
is distributed to distinct localizations in the cell through diverse pathways. We demonstrate here that the delivery of
copper
to copper/zinc superoxide dismutase (SOD1) is mediated through a soluble factor identified as Saccharomyces cerevisiae LYS7 and human CCS (
copper
chaperone for SOD). This factor is specific for SOD1 and does not deliver
copper
to proteins in the mitochondria, nucleus, or secretory pathway. Yeast cells containing a lys7Delta null mutation have normal levels of SOD1 protein, but fail to incorporate
copper
into SOD1, which is therefore devoid of superoxide scavenging activity. LYS7 and CCS specifically restore the biosynthesis of holoSOD1 in vivo. Elucidation of the CCS
copper
delivery pathway may permit development of novel therapeutic approaches to human diseases that involve SOD1, including
amyotrophic lateral sclerosis
.
...
PMID:The copper chaperone for superoxide dismutase. 929 78
Although a consensus that Alzheimer's disease (AD) is a single disease has not been reached yet, the involvement of the amyloid precursor protein (APP) and betaA4 (A beta) in the pathologic changes advances our understanding of the underlying molecular alterations. Increasing evidence implicates oxidative stress in the neurodegenerative process of AD. This hypothesis is based on the toxicity of betaA4 in cell cultures, and the findings that aggregation of betaA4 can be induced by metal-catalyzed oxidation and that free oxygen radicals may be involved in APP metabolism. Another neurological disorder, familial
amyotrophic lateral sclerosis
(FALS), supports our view that AD and FALS may be linked through a common mechanism. In FALS, SOD-Cu(I) complexes are affected by hydrogen peroxide and free radicals are produced. In AD, the reduction of
Cu(II)
to Cu(I) by APP involves an electron-transfer reaction and could also lead to a production of hydroxyl radicals. Thus,
copper
-mediated toxicity of APP-
Cu(II)
/(I) complexes may contribute to neurodegeneration in AD.
...
PMID:Reactive oxygen species and Alzheimer's disease. 933 68
Approximately 20% of cases of familial
amyotrophic lateral sclerosis
are caused by dominant mutations in the Cu,Zn superoxide dismutase. One such mutant, in which histidine #48 has been replaced by glutamine (H48Q), exhibits a novel activity. It can react sequentially with O2- and H2O2 to generate a potent oxidant at its active site, possibly
Cu(II)
-OH, which then can oxidize urate to the corresponding radical. This O2- -dependent peroxidase activity exerted on a substrate peculiar to motor neurons may be the toxic gain of function which leads to the deleterious consequences of this mutation. G93A, G93R, and E100G were also examined and found not to exert this O2- -dependent peroxidase activity.
...
PMID:Superoxide-dependent peroxidase activity of H48Q: a superoxide dismutase variant associated with familial amyotrophic lateral sclerosis. 934 73
Mutations in human Cu/Zn superoxide dismutase-1 (SOD) cause approximately 20% of cases of familial
amyotrophic lateral sclerosis
(FALS). We investigated the mechanism of mutant SOD-induced neuronal degeneration by expressing wild-type and mutant SODs in neuronal cells by means of infection with replication-deficient recombinant adenoviruses. Expression of two FALS-related mutant SODs (A4V and V148G) caused death of differentiated PC12 cells, superior cervical ganglion neurons, and hippocampal pyramidal neurons. Cell death included many features typical of apoptosis. Death could be prevented by
copper
(
Cu2+
) chelators, Bcl-2, glutathione, vitamin E, and inhibitors of caspases. Mutant SOD-expressing PC12 cells had higher rates of superoxide (O2-) production under a variety of conditions. The results support the hypothesis that mutant SOD induced-neurodegeneration is associated with disturbances of neuronal free radical homeostasis.
...
PMID:Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. 934 45
Mutations to Cu/Zn superoxide dismutase (SOD) linked to familial
amyotrophic lateral sclerosis
(
ALS
) enhance an unknown toxic reaction that leads to the selective degeneration of motor neurons. However, the question of how >50 different missense mutations produce a common toxic phenotype remains perplexing. We found that the zinc affinity of four
ALS
-associated SOD mutants was decreased up to 30-fold compared to wild-type SOD but that both mutants and wild-type SOD retained
copper
with similar affinity. Neurofilament-L (NF-L), one of the most abundant proteins in motor neurons, bound multiple zinc atoms with sufficient affinity to potentially remove zinc from both wild-type and mutant SOD while having a lower affinity for
copper
. The loss of zinc from wild-type SOD approximately doubled its efficiency for catalyzing peroxynitrite-mediated tyrosine nitration, suggesting that one gained function by SOD in
ALS
may be an indirect consequence of zinc loss. Nitration of protein-bound tyrosines is a permanent modification that can adversely affect protein function. Thus, the toxicity of
ALS
-associated SOD mutants may be related to enhanced catalysis of protein nitration subsequent to zinc loss. By acting as a high-capacity zinc sink, NF-L could foster the formation of zinc-deficient SOD within motor neurons.
...
PMID:Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. 934 38
We report the clinical, genetic, and neuropathologic findings in a patient with rapidly progressive familial
amyotrophic lateral sclerosis
(
ALS
). We detected a point mutation at codon 48 of the Cu/Zn superoxide dismutase gene (SOD1) leading to a substitution of histidine by glutamine in the
copper
-binding domain. The histopathologic features are consistent with those described in rapidly progressive sporadic
ALS
and do not support claims that sporadic and familial disease are different pathologic entities. Neurofilamentous accumulations, hyaline, and ubiquitinated inclusions were present in the motor cortex, brainstem, and anterior horn cells, but there was no evidence of abnormal SOD1 immunoreactivity. This confirms that the cytoskeletal pathology specific to
ALS
is secondary to an unknown biochemical disturbance caused by mutant SOD1 molecules and not its toxic accumulation.
...
PMID:Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. 940 55
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>